MedPath

Milk Types and Fish Oil in 9- to 12-Month-Old Infants

Not Applicable
Completed
Conditions
Obesity
Metabolic Syndrome
Growth
Blood Pressure
Cardiovascular Disease
Registration Number
NCT00379171
Lead Sponsor
University of Copenhagen
Brief Summary

The objective of this intervention study is to examine the effect of whole cow's milk versus infant formula as primary milk sources with or without supplements of n-3 LCPUFA for growth, nutritional status, development, risk factors for later diseases and the impact on the intestinal microbiota and inflammation in 9 - 12 months old infants.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Singleton infants
  • Born >= 37 wk of gestation
  • Birth weight > 2500g
  • >= 5th percentile for gestational age
  • A 5-min Apgar score >= 7
  • Daily consumption of cow's milk or formula
Exclusion Criteria
  • No major complications at birth or in fetal life
  • No chronic diseases

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
Growth
Body composition (weight, length, knee-heel-length, waist, head, and arm circumference, skin fold measurements).
IGF-I
IGFBP-3
Insulin - glucose metabolism (HOMA index).
Urea Nitrogen
Albumin
C-peptide
Amino Acids
Erythrocyte fatty acid composition
Blood pressure
Lipid Profile
Heart Rate Variability (HRV)
In vitro cytokine production from stimulated full blood (IL-10, IFN-gamma, TNF-alpha)
Plasma IgE, IL-2R, and CRP
Secondary Outcome Measures
NameTimeMethod
Plasma concentrations of cholesterol and triglycerides
Allergy status
Cognitive test ("The infant means-end problem solving test")
Iron status (hemoglobin, ferritin and transferrin receptors)
Feces samples: Calprotectin, IgA and composition of the intestinal microbiota
© Copyright 2025. All Rights Reserved by MedPath